Haider MR - Search Results

1

Novel 9-(2-(1-arylethylidene)hydrazinyl)acridine derivatives: Target Topoisomerase 1 and growth inhibition of HeLa cancer cells.

Haider MR, Ahmad K, Siddiqui N, Ali Z, Akhtar MJ, Fuloria N, Fuloria S, Ravichandran M, Yar MS. Haider MR, et al. Bioorg Chem. 2019 Jul;88:102962. doi: 10.1016/j.bioorg.2019.102962. Epub 2019 May 3. Bioorg Chem. 2019. PMID: 31085373

2

Recent Advances in the Synthesis and Anticancer Activity of Some Molecules Other Than Nitrogen Containing Heterocyclic Moeities.

Akhtar MJ, Yar MS, Khan AA, Ali Z, Haider MR. Akhtar MJ, et al. Among authors: haider mr. Mini Rev Med Chem. 2017;17(17):1602-1632. doi: 10.2174/1389557516666161031121639. Mini Rev Med Chem. 2017. PMID: 27804888 Review.

3

Design and synthesis of quinazoline-3,4-(4H)-diamine endowed with thiazoline moiety as new class for DPP-4 and DPPH inhibitor.

Ali Z, Akhtar MJ, Haider MR, Khan AA, Siddiqui AA, Yar MS. Ali Z, et al. Among authors: haider mr. Bioorg Chem. 2017 Apr;71:181-191. doi: 10.1016/j.bioorg.2017.02.004. Epub 2017 Feb 10. Bioorg Chem. 2017. PMID: 28215601

4

Design, Synthesis, and Biological Evaluation of Novel Quinazoline Clubbed Thiazoline Derivatives.

Ali Z, Akhtar MJ, Siddiqui AA, Khan AA, Haider MR, Yar MS. Ali Z, et al. Among authors: haider mr. Arch Pharm (Weinheim). 2017 Feb;350(2). doi: 10.1002/ardp.201600298. Epub 2017 Jan 17. Arch Pharm (Weinheim). 2017. PMID: 28093794

5

DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspective.

Pathak A, Rohilla A, Gupta T, Akhtar MJ, Haider MR, Sharma K, Haider K, Yar MS. Pathak A, et al. Among authors: haider mr, haider k. Eur J Med Chem. 2018 Oct 5;158:559-592. doi: 10.1016/j.ejmech.2018.08.093. Epub 2018 Sep 11. Eur J Med Chem. 2018. PMID: 30243157 Review.

6

Anti-tubulin agents of natural origin: Targeting taxol, vinca, and colchicine binding domains.

Naaz F, Haider MR, Shafi S, Yar MS. Naaz F, et al. Among authors: haider mr. Eur J Med Chem. 2019 Jun 1;171:310-331. doi: 10.1016/j.ejmech.2019.03.025. Epub 2019 Mar 14. Eur J Med Chem. 2019. PMID: 30953881 Review.

7

Medicinal prospects of antioxidants: A review.

Neha K, Haider MR, Pathak A, Yar MS. Neha K, et al. Among authors: haider mr. Eur J Med Chem. 2019 Sep 15;178:687-704. doi: 10.1016/j.ejmech.2019.06.010. Epub 2019 Jun 13. Eur J Med Chem. 2019. PMID: 31228811 Review.

8

Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review.

Haider K, Pathak A, Rohilla A, Haider MR, Ahmad K, Yar MS. Haider K, et al. Among authors: haider mr. Eur J Med Chem. 2019 Dec 15;184:111773. doi: 10.1016/j.ejmech.2019.111773. Epub 2019 Oct 12. Eur J Med Chem. 2019. PMID: 31630053 Review.

9

Free radical scavengers: An overview on heterocyclic advances and medicinal prospects.

Haider K, Haider MR, Neha K, Yar MS. Haider K, et al. Among authors: haider mr. Eur J Med Chem. 2020 Oct 15;204:112607. doi: 10.1016/j.ejmech.2020.112607. Epub 2020 Jul 15. Eur J Med Chem. 2020. PMID: 32721784 Review.

10

Emergence of promising novel DPP-4 inhibitory heterocycles as anti-diabetic agents: A review.

Rohilla A, Gupta T, Pathak A, Akhtar MJ, Haider MR, Haider K, Shahar Yar M. Rohilla A, et al. Among authors: haider mr, haider k. Arch Pharm (Weinheim). 2018 Jun 7:e1800127. doi: 10.1002/ardp.201800127. Online ahead of print. Arch Pharm (Weinheim). 2018. PMID: 29878387 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters